Skip to main content
SpringerLink
Log in

Prevalence of hematological abnormalities in patients with Sheehan’s syndrome: response to replacement of glucocorticoids and thyroxine

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Anemia and other hematological abnormalities are common in patients with Sheehan’s syndrome. The response of these abnormalities to replacement of thyroxine and glucocorticoids is not clear. The aim of the present study was to document the profile of hematological abnormalities and response to treatment in patients with Sheehan’s syndrome. Forty patients of Sheehan’s syndrome and an equal number of age and parity matched healthy controls were studied for prevalence of hematological abnormalities. Hemoglobin concentration, hematocrit, red cell, white cell and platelet count were significantly decreased in patients with Sheehan’s syndrome compared to controls. Frequency of anemia, leucopenia, thrombocytopenia and pancytopenia was significantly higher in these patients compared to controls. After achieving euthyroid and eucortisol state, there was a complete recovery of these hematological abnormalities. We conclude that anemia and other cytopenias are common in patients with Sheehan’s syndrome and replacement with thyroxine and glucocorticoids results in complete recovery of these abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sheehan HL (1937) Postpartum necrosis of the anterior pituitary. J Pathol Bact 45:189–214

    Article  CAS  Google Scholar 

  2. Zargar AH, Singh B, Laway BA, Masoodi SR, Wani AI, Bashir MI (2005) Epidemiological aspects of postpartum pituitary hypofunction (Sheehan’s syndrome). Fertil Steril 84:523–528

    Article  PubMed  Google Scholar 

  3. Kelestimur F (2003) Sheehan’s syndrome. Pituitary 6:181–188

    Article  PubMed  Google Scholar 

  4. Gokalp D, Tuzcu A, Bahceci M, Arikan S, Bahceci S, Pasa S (2009) Sheehan’s syndrome as a rare cause of anaemia secondary to hypopituitarism. Ann Hematol 88:405–410

    Article  PubMed  Google Scholar 

  5. Laway BA, Bhat JR, Mir SA, Khan RSZ, Lone MI, Zargar AH (2010) Sheehan’s syndrome with pancytopenia–complete recovery after hormone replacement. Ann Hematol 89:305–308

    Article  PubMed  Google Scholar 

  6. Laway BA, Ganie MA, Butt TP, Zargar AH (2009) Multiple spontaneous pregnancies in Sheehan syndrome with preserved gonadotrophin function. The Endocrinologist 19:253–254

    Article  Google Scholar 

  7. Zargar AH, Masoodi SR, Laway BA, Shah NA, Salahuddin M, Siddiqi MA (1996) Clinical spectrum of Sheehan’s syndrome. Ann Saudi Med 16:338–341

    CAS  PubMed  Google Scholar 

  8. Goswami R, Kochupillai N, Crock PA, Jaleel A, Gupta N (2002) Pituitary autoimmunity in patients with Sheehan’s syndrome. J Clin Endocrinol Metab 87:4137–4141

    Article  CAS  PubMed  Google Scholar 

  9. Feigin WM, Gordon AS (1950) Influence of hypophysectomy on the hemopoietic response of rats to lowered barometric pressure. Endocrinology 47:364–369

    Article  CAS  PubMed  Google Scholar 

  10. Lindeman RD, Trygstad O, Halvorsen S (1969) Pituitary control of erythropoiesis. Scand J Hematol 6:77–86

    Article  Google Scholar 

  11. Naina VK, Harris S (2010) Platelet and red blood cell indices in Harris platelet syndrome. Platelets 21:303–306

    Article  CAS  PubMed  Google Scholar 

  12. Nagy E, Berczi (1989) Pituitary dependence of bone marrow function. British J Haematol 71:457–462

    Article  CAS  Google Scholar 

  13. Peschle C, Rappaport IA, Magli MC, Marone G, Lettieri F, Cillo C, Gordon AS (1978) Role of hypophysis in erythropoietin production during hypoxia. Blood 51:1117–1124

    CAS  PubMed  Google Scholar 

  14. Jepson JH, McGarry EE (1972) Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone. Blood 39:229–248

    CAS  PubMed  Google Scholar 

  15. Godle DW, Bersch N, Cline MJ (1976) Potentiation of erythropoiesis in vitro by dexamethasone. J Clin Invest 57:57–62

    Article  Google Scholar 

  16. Godle DW, Bersch N, Chopra IJ, Cline MJ (1977) Thyroid hormones stimulate erythropoiesis in vitro. British J Haematol 37:173–177

    Article  Google Scholar 

  17. Sohmiya M, Kato Y (2001) Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency. Clin Endocrinol (Oxf) 55:749–754

    Article  CAS  Google Scholar 

  18. Zellweger R, Zhu XH, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH (1996) Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol 157:5748–5754

    CAS  PubMed  Google Scholar 

  19. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K (1997) Defective mammopoiesis, but normal hematopoiesis, in mice with targeted disruption of the prolactin gene. EMBO J 16:6926–6935

    Article  CAS  PubMed  Google Scholar 

  20. Nishioka H, Haraoka J (2005) Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and/or levothyroxine. J Endocrinol Invest 28:528–533

    CAS  PubMed  Google Scholar 

  21. Ishikawa K, Sohmiya M, Furuya H, Kato Y (1995) A case of Sheehan’s syndrome associated with severe anemia and empty sella proved 48 years after the post-partum hemorrhage. Endocr J 42:803–809

    Article  CAS  PubMed  Google Scholar 

  22. Ferrari E, Ascari E, Bossolo DA, Barosi G (1976) Sheehan’s syndrome with complete bone marrow aplasia: long term results of substitution therapy with hormones. Br J Haematol 33:575–582

    Article  CAS  PubMed  Google Scholar 

  23. Nomiyama J, Shinohara K, Inoue H (1994) Improvement of anemia by recombinant ery thropoietin in a patient with postoperative hypopituitarism. Am J Hematol 47:249–250

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Sher-I- Kashmir Institute of Medical Sciences Soura, Srinagar, Jammu and Kashmir, India

    Bashir Ahmad Laway, Shahnaz Ahmad Mir, Mir Iftikhar Bashir & Abdul Hamid Zargar

  2. Department of Clinical Hematology, Sher-I- Kashmir Institute of Medical Sciences Soura, Srinagar, Jammu and Kashmir, India

    Javid Rasool Bhat & Jeelani Samoon

Authors
  1. Bashir Ahmad Laway
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahnaz Ahmad Mir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mir Iftikhar Bashir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Javid Rasool Bhat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeelani Samoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abdul Hamid Zargar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdul Hamid Zargar.

Additional information

Reversible hematological abnormalities in Sheehan’s syndrome.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laway, B.A., Mir, S.A., Bashir, M.I. et al. Prevalence of hematological abnormalities in patients with Sheehan’s syndrome: response to replacement of glucocorticoids and thyroxine. Pituitary 14, 39–43 (2011). https://doi.org/10.1007/s11102-010-0255-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-010-0255-2

Keywords

Search

Navigation